ConductScience.org, home

Paper407841

Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers.

Schmidt LH and 3 others. Antimicrob Agents Chemother, 1977. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers. Papers, record 407841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/407841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmidt LHL H
2Alexander SS
3Allen LL
4Rasco JJ

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MalariaMajor topic
PrimaquineMajor topic
Animals
Female
Haplorhini
Lethal Dose 50
Macaca mulatta
Male
Mice
Stereoisomerism
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02898779Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1Results

Source ClinicalTrials.gov

Download CSV of trials

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
213793053
Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report.
Bull World Health Organ1960https://conductscience.org/library/papers/13793053PubMed
314044759THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI.Am J Trop Med Hyg1963https://conductscience.org/library/papers/14044759PubMed
65795444Malaria imported to the United States from Vietnam. Chemoprophylaxis evaluated in returning soldiers.Am J Trop Med Hyg1969https://conductscience.org/library/papers/5795444PubMed
9405875The characteristics of Plasmodium cynomolgi infections in various old world primates.Am J Trop Med Hyg1977https://conductscience.org/library/papers/405875PubMed
10326072Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.Am J Trop Med Hyg1977https://conductscience.org/library/papers/326072PubMed

Download CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
36726785Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration.Front Pharmacol2022https://conductscience.org/library/papers/36726785PubMed
35709685Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers.Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/35709685PubMed
35659684Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.Malar J2022https://conductscience.org/library/papers/35659684PubMed
35123453Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice.Malar J2022https://conductscience.org/library/papers/35123453PubMed
32073254Tafenoquine: A Step toward Malaria Elimination.Biochemistry2020https://conductscience.org/library/papers/32073254PubMed
31750830Oral acute and sub-acute toxic effects of hydroalcoholic Terminalia chebula Retz and Achillea wilhelmsii extracts in BALB/c mice.Biomedicine (Taipei)2019https://conductscience.org/library/papers/31750830PubMed
27093859Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.Malar J2016https://conductscience.org/library/papers/27093859PubMed
25518709Enantioselective metabolism of primaquine by human CYP2D6.Malar J2014https://conductscience.org/library/papers/25518709PubMed
25267666Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).Antimicrob Agents Chemother2014https://conductscience.org/library/papers/25267666PubMed
24913163Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24913163PubMed
21947400Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21947400PubMed
18378716Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18378716PubMed
14674788Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.Clin Pharmacokinet2003https://conductscience.org/library/papers/14674788PubMed
11914150Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?BMC Public Health2002https://conductscience.org/library/papers/11914150PubMed
6976854New tissue schizontocidal antimalarial drugs.Bull World Health Organ1981https://conductscience.org/library/papers/6976854PubMed
6976853Considerations about the structure-activity relationships of 8-aminoquinoline antimalarial drugs.Bull World Health Organ1981https://conductscience.org/library/papers/6976853PubMed
117747Antimalarial properties of floxacrine, a dihydroacridinedione derivative.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/117747PubMed
98104Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine).Antimicrob Agents Chemother1978https://conductscience.org/library/papers/98104PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
PRIMAQUINECHEMBL506Results1https://conductscience.org/library/drugs/CHEMBL506

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/407841

GET https://conductscience.org/api/papers/v1/407841/authors